[1]
PANDA, A.R. and DAS, S. 2024. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL. International Journal of Pharmacy and Pharmaceutical Sciences. 16, 09 (Sep. 2024), 1–7. DOI:https://doi.org/10.22159/ijpps.2024v16i9.51048.